approval · primary record
LONCASTUXIMAB TESIRINE-LPYL
FDA · BLA · 2026-02-20
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-02-20 |
| Brand | ZYNLONTA |
| Sponsor | ADC Therapeutics SA |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:31:06.228Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:LONCASTUXIMAB TESIRINE-LPYL:2026-02-20
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.